Floating Button
Home Capital Broker's Calls

PhillipCapital keeps ‘buy’ on 17Live but cuts target price on softer growth assumptions

Samantha Chiew
Samantha Chiew • 2 min read
PhillipCapital keeps ‘buy’ on 17Live but cuts target price on softer growth assumptions
PhillipCapital expects negative growth to gradually narrow. Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

PhillipCapital is reiterating its “buy” call on Singapore’s first and only successfully Spac listed company 17Live, but has dropped target price to $1.18 from $1.45 previously.

This comes on the back of the live streaming platform operator’s recent FY2025 ended Dec 31, 2025 results announcement, which saw the group turn profitable for the 2HFY2025 period – it reported earnings of US$3.68 million compared to a loss of US$5.21 million the same period a year ago.

On a full-year basis, the group is still in the red, but losses have narrowed to US$924,000 from US$3.27 million in FY2024.

Revenue however did not see growth. The group posted operating revenue of US$158.8 million for 2025, a decrease of 16.8% y-o-y, primarily from Liver live streaming. The group’s revenue from V-Liver live streaming increased slightly from US$11.0 million in FY2024 to US$11.1 million in FY2025.

Revenue for 2HFY2025 came in at US$77.6 million, a decline from US$89.7 million a year ago.

17Live declared a final dividend of 0.5 cents per share. Including its interim dividend of 1.5 cents per share, the total dividend payout for FY2025 is 2.0 cents.

See also: PhillipCapital upgrades Ever Glory United to ‘buy’ with higher TP of $1.05

See more: 17Live posts profits of US$3.7 mil in 2HFY2025

Analysts Serena Lim and Paul Chew note that while the group had turnaround a profit in 2HFY2025, earnings were below expectations.

“We reduced our FY2026 revenue and Patmi forecasts by 25% and 37.5%, respectively, reflecting softer growth assumptions for the live-streaming market, slower monetisation trends, and a longer ramp-up period for new initiatives to contribute meaningfully to earnings. We continue to expect a consistent dividend policy and management’s ongoing share buyback programme,” say Lim and Chew.

See also: PhillipCapital and OCBC Group Research keeping their respective ‘buy’ calls on Nordic following recent FY2025 results

In addition, 17Live continues to execute share buyback programme launched in 2024, with authority to repurchase up to 10% of issued share capital. As of 2HFY2025, 9 million shares worth of US$6.8 million ($8.9 million) have been bought back, representing about 53% of the authorised limit under the current mandate.

However, Lim and Chew are cautious on the negative growth from core segments at the moment.

“We expect the negative growth in the core segment (2HFY2024: -34%) to gradually narrow as the removal of exclusive contracts and ongoing events attract top-active streamers from competitors. This should boost monthly active users, particularly in Japan, and support higher conversion to paying clients, with revenue impact likely to materialise in FY2026,” they say.

As at 11.30am, shares in 17Live are trading at 85 cents.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.